180 likes | 197 Views
This program provides an overview of treatment options for post-myocardial infarction (MI) patients with left ventricular dysfunction (LVD). It explores the influence of LV dysfunction on post-MI outcomes, the predictive value of markers of organ damage, and the targeting of neurohormonal pathways. The ESC guideline recommendations and distinguishing between agents in the same class are discussed. The program also covers the cardioprotective effects of Zofenopril and the effects of ACE inhibitors on endothelial stress. SMILE-4, a subanalysis focusing on ACE inhibitors in combination with aspirin, and SMILE-ISCHEMIA, analyzing patients with preserved LV function, are included. Conclusions and abbreviations are provided.
E N D
Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?
Distinguishing Between Agents in the Same Class: Considerations
SMILE-4: Distinguishing Between ACE Inhibitors in Combination With Aspirin
SMILE-ISCHEMIA: Analysis of Patients With Preserved LV Function